PD07 Economic Analysis Of Visualase Laser Interstitial Thermal Therapy For Tumors In Australia
Rashmi Joglekar, Gail Dechochai, Santwona Baidya · 2025
Read PD07 Economic Analysis Of Visualase Laser Interstitial Thermal Therapy For Tumors In Australia by Rashmi Joglekar, Gail Dechochai, Santwona Baidya (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12768740.txt.
Description
A laser therapy called Visualase burns brain tumors through a thin probe, guided by live MRI, instead of opening the skull. Rashmi Joglekar and co-authors weigh its cost against open surgery for Australian patients. Lacking local outcome data, they drew clinical figures from studies abroad and priced care with national fee schedules.
Cost per life year gained came to about AUD 87,630 for returning primary tumors. For returning spread tumors it was about AUD 24,630, and for radiation damage about AUD 15,948. Against a rough AUD 50,000 yardstick, the therapy pays off for some groups only. Hospital stays shrank from four days to one, the 2025 analysis notes.
Catalog record
| CREATOR | Rashmi Joglekar, Gail Dechochai, Santwona Baidya |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |